Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector™ Assay Kit for Non-Small Cell Lung Cancer Patients

SAN DIEGO–(BUSINESS WIRE)–Biocept and Protean BioDiagnostics Collaborate to Demonstrate Advantages of Biocept’s Target Selector Assay for Non-Small Cell Lung Cancer Patients.

Click to view original post

Advertise With Us